Table 4.
Therapy/prophylaxis | Drug | Therapeutic regimen |
---|---|---|
Acute therapy | ||
First choice | Fluconazole |
200 mgb/100 mg 1×/day p.o. for oral candidiasis (topical therapy only in very mild cases) for 5–14 days 1 × 200 (–400) mg p.o. for esophageal candidiasis (twice the dose on the first day in each case) for 10–14 days If Fluconazole not tolerated p.o., it might be given i.v. |
Alternatives (in moderate cases) | Amphotericin | Suspension 4 × 1 ml (100 mg) up to 48 h after symptoms resolve |
Nystatin | 4 × 1 ml (100,000 I.E.) up to 48 h after symptoms resolve | |
Alternatives in case of fluconazole intolerance | Itraconazole | 400 mg loading days 1-3b/then 100–200 mg 2×/day p.o. (only as suspension due to poor bio-availability of capsules) |
Posaconazole | 400 mg 2×/day p.o. (suspension) | |
Voriconazole | 400 mgb/200 mg 2×/day p.o. | |
Alternatives for Azole failure | Anidulafungin | 200 mgb/100 mg 1×/day i.v. |
Caspofungin | 70 mgb/50 mg 1×/day i.v. | |
Micafungin | 150 mg 1×/day i.v. | |
Prophylaxis | ||
Primary prophylaxis | Not recommended | |
Secondary prophylaxis | In individual cases, generally not recommended | |
Amphotericin | Suspension 4×1 ml/day p.o. (100 mg) | |
Fluconazole | If necessary 50 mg every 48 h or 150 mg 1×/week |
aDaily doses
bKeep in mind the loading dose on the first day; with itraconazole for at least 3 days